| BCBS Highmark NY and West NY | Rituximab (Rituxan), Rituximab Biosimilars, and Rituximab and Hyaluronidase Human (Rituxan Hycela) | 2026-01-12 |
| BCBS Highmark NY and West NY | Romosozumab-aqqg (Evenity) | 2026-01-12 |
| Medicare CGS | Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (56973) | 2026-01-12 |
| Medicare CGS | Billing and Coding: Removal of Benign Skin Lesions (57044) | 2026-01-12 |
| Medicare CGS | Billing and Coding: MolDX: Proteomics Testing (59646) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (57037) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Blood Product Molecular Antigen Typing (57124) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Melanoma Risk Stratification Molecular Testing (57268) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Breast Cancer Assay: Prosigna– (57363) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Envisia–, Veracyte–, Idiopathic Pulmonary Fibrosis Diagnostic Test (57419) | 2026-01-12 |